We have previously reported that
insulin-like growth factor-I (
IGF-I) supports growth and survival of mouse and human
medulloblastoma cell lines, and that
IGF-I receptor (IGF-IR) is constitutively phosphorylated in human
medulloblastoma clinical samples. Here, we demonstrate that a specific inhibitor of
insulin-like growth factor-I receptor (IGF-IR),
NVP-AEW541, attenuated growth and survival of mouse (BsB8) and human (D384, Daoy)
medulloblastoma cell lines. Cell cycle analysis demonstrated that G1 arrest and apoptosis contributed to the action of NVP-AEW54. Interestingly, very aggressive BsB8 cells, which derive from
cerebellar tumors of transgenic mice expressing viral
oncoprotein (
large T-antigen from human polyomavirus JC) became much more sensitive to
NVP-AEW541 when exposed to anchorage-independent culture conditions. This high sensitivity to NVP-AEW54 in
suspension was accompanied by the loss of
GSK-3beta constitutive phosphorylation and was independent from
T-antigen-mediated cellular events (Supplementary Materials). BsB8 cells were partially rescued from
NVP-AEW541 by
GSK3beta inhibitor,
lithium chloride and were sensitized by
GSK3beta activator,
sodium nitroprusside (SNP). Importantly, human
medulloblastoma cells, D384, which demonstrated partial resistance to
NVP-AEW541 in
suspension cultures, become much more sensitive following SNP-mediated
GSK3beta dephosphorylation (activation). Our results indicate that
hypersensitivity of
medulloblastoma cells in anchorage-independence is linked to
GSK-3beta activity and suggest that pharmacological intervention against IGF-IR with simultaneous activation of
GSK3beta could be highly effective against
medulloblastomas, which have intrinsic ability of disseminating the CNS via cerebrospinal fluid.